12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)
It may seem hard to believe, but some stocks are expected to rise by 50%, 100%, or even more over the next year. Our own DJIA peak price target is up 11.3% at 14,590, and that is a far cry from gains of 50% and 100%. 24/7 Wall St. has screened through many Wall St. research reports issued in the days from right before Christmas until now. As it turns out, the past two weeks have many big analyst calls seeking for gains of 50% to 100% (or even more) in some select stocks. Some of these companies have a black eye, or they have recently been in the news, and many of them are not exactly household names.
24/7 Wall St. has identified 12 stocks with massive upside according to the analysts that follow them. Will they all rise 50% or 100%? That seems highly unlikely. Still, this list is one for speculative investors willing to invest in very speculative companies. It is no surprise that biotech is represented, and only one of these 12 companies has a market value above $1 billion. In many cases the market caps are tiny.
You probably will notice that none of these research calls are from Goldman Sachs, Merrill Lynch and other bulge-bracket firms. There is also a reason you do not see names like IBM, 3M, GE and other great companies that are expected to rise by 50%, 100% or more. The large research and brokerage firms tend to follow larger companies, and they tend to be far more conservative in their price targets.
The key upside of 50% to 100% (and more) calls were made in the following companies: Amarin Corp. (NASDAQ: AMRN), Carrizo Oil & Gas Inc. (NASDAQ: CRZO), Coronado Biosciences Inc. (NASDAQ: CNDO), EMCORE Corp. (NASDAQ: EMKR), EnteroMedics Inc. (NASDAQ: ETRM), Exact Sciences Corp. (NASDAQ: EXAS), Galena Biopharma Inc. (NASDAQ: GALE), MagnaChip Semiconductor Corp. (NYSE: MX), Osage Exploration and Development Inc. (OTC: OEDV), Renewable Energy Group Inc. (NASDAQ: REGI), SunPower Corp. (NASDAQ: SPWR) and Synergy Pharmaceuticals Inc. (NASDAQ: SGYP).
Again, these calls of 50% to 100% upside are all from existing Wall St. analysts or independent research analysts. We have provided a brief note regarding the research reports, what the implied upside is, and added color and background data on each in the following summaries.
Filed under: 24/7 Wall St. Wire, Active Trader, Analyst Calls, Biotech, Cult Stock, Value Investing Tagged: AMRN, CNDO, CRZO, EMKR, ETRM, EXAS, featured, GALE, MX, OEDV, REGI, SGYP, SPWR